Article Details

WuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager

Retrieved on: 2025-01-07 00:33:54

Tags for this article:

Click the tags to see associated articles and topics

WuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager. View article details on hiswai:

Excerpt

... antibodies, addressing the growing global demand for these complex molecules. ... Bispecific Monoclonal Antibody · Cd20 · Trichloroethylene · Immune ...

Article found on: www.cnhinews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo